CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

CCL22 is a macrophage-derived immunosuppressive chemokine that recruits regulatory T cells through the CCL22:CCR4 axis. CCL22 was shown to play a key role in suppressing anti-cancer immune responses in different cancer types. Recently, we showed that CCL22-specific T cells generated from cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecoq, Inés, Kopp, Katharina L., Chapellier, Marion, Mantas, Panagiotis, Martinenaite, Evelina, Perez-Penco, Maria, Rønn Olsen, Lars, Zocca, Mai-Britt, Wakatsuki Pedersen, Ayako, Andersen, Mads Hald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427044/
https://www.ncbi.nlm.nih.gov/pubmed/36052217
http://dx.doi.org/10.1080/2162402X.2022.2115655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427044/
https://www.ncbi.nlm.nih.gov/pubmed/36052217
http://dx.doi.org/10.1080/2162402X.2022.2115655

Ejemplares similares